Luca Savi
Analyst · Melius Research
Thank you, Carleen, and good morning. Let me begin by thanking our employees around the world who have delivered another outstanding quarter. Our results are a direct reflection of the hard work we do at ITT, each and every day for our customers and our shareholders. I couldn't be more proud and I can assure you there is more to come. I would also like to extend a special thank you to our colleagues at Habonim in Israel and Goulds Pumps in Saudi, who continue to excel in extremely challenging environment. Ilan, Kalim and their teams have demonstrated remarked resilience whilst continuing to deliver quarter after quarter. Their unwavering commitment to serve our customers is second to none. This is the very best of ITT. Now turning to the highlights to our third quarter. We grew orders 58% or 20% organically. We grew revenue for 44% or 8% organically, reflecting a book-to-bill of 1.08 for the quarter. We expanded operating margin 140 basis points reaching 21% for the very first time. We delivered EPS of $2.26, up 20% year-over-year. And finally, we generated $464 million of free cash flow year-to-date, up 26% from the prior year, a truly outstanding quarter. Let's get now into the details on orders. Orders are once again the highlight of the quarter, with continued aerospace recovery, defense content expansion healthy project activity and ongoing market share gains across the portfolio. CCT continued its strong momentum from Q2, growing organic orders 55%, driven by aerospace tailwinds and defense share gains. In defense, kSARIA keeps on winning market share and achieved 146% growth in orders, driven by awards in submarine, tactical radio platforms and the F-35 with a very healthy backlog for the short and medium term and our growing participation across key defense programs that provide multiyear visibility ,kSARIA will be a significant platform for growth in the years to come. Connectors also grew 37% in the quarter, driven by broad-based trend across all regions, all channels and all end markets. In Motion Technologies, we continue to strengthen our position through a combination of platform rewins and conquest awards that will fuel future market share gains in friction. In KONI, orders were strong again this quarter, growing 24%, driven by strength in rail and European defense, including a significant order for Patria. And finally, Flow Technologies delivered 108% orders growth, with organic orders up 11%, driven by key project wins in oil and gas, including Venezuela and in marine energy transition alongside continued strength in biopharma for our valves business. In SPX FLOW, mixers delivered 6% growth from large project orders in North America and China. While Waukesha Cherry-Burrell grew 10%, driven by strong original equipment run rate through North America distribution. On revenue, Organic growth across all segments contributed to another quarter of strong performance, underscoring once again the power of ITT's differentiation. In CCT, organic revenue grew 19%. Commercial aerospace continue to benefit from increasing production rates and pricing actions whilst defense growth was bolstered by European Defense wins coupled with kSARIA's expanding presence on marquee programs. Connectors also grew its industrial segment 31% globally, mainly through distribution. MT once again outperformed global vehicle production across all regions, resulting in a year-to-date outperformance of 506 basis points. Flow Technologies grew revenue 99% or 6% organically, led by sustained momentum in pump projects and strength in our short-cycle valves businesses. Valves revenue increased 20% and we still generated a healthy 1.2 book-to-bill. Finally, SPX FLOW revenue grew 6% in Q3 and 8% year-to-date, keeping the business on track to deliver high single-digit growth for the full year, supported by strength in Nutrition & Health, Waukesha Cherry-Burrell and mixers. On operating margin, CCT margins expanded 100 basis points year-over-year to a record 22%. Volume and pricing actions more than offset inflationary pressures. We continue to invest in resources, in automation and capacity to deliver today's backlog and capture tomorrow's share gains. kSARIA also contributed to CCT's performance expanding margin to over 19%, benefiting from pricing and operating leverage. Well done, my team, for kSARIA's margin expansion as well as revenue growth and order. Motion Technologies expanded margins 70 basis points to 21% as net productivity more than offset customer pricing pressures in friction. Flow Technologies delivered a margin of 22.4%, improving 100 basis points sequentially as integration synergies accelerate. All of this contributed to EPS growth of 20% to $2.26. Now to cash capital deployment. In Q3, we generated $288 million of free cash flow, bringing our year-to-date total to $464 million. With this strong cash performance, we paid down over $200 million of debt and reduced our leverage ratio to 2.3x. We now expect the year-end ratio to be approximately 2.1x. We also continue to repurchase shares, $50 million in Q3 and over $150 million year-to-date. In the quarter, we also acquired Aerospace Contacts, strengthening our supply chain and improving our ability to support future growth in CCT. While on the topic of M&A, it has been 8 months since we completed our largest acquisition, SPX FLOW. Let me now share our progress on the 2 biggest drivers of value creation, growth and cost synergies. On the growth front, year-to-date revenue growth of 8% was driven by strength in Nutrition & Health, which has grown 16% year-to-date as a result of a healthy backlog. This performance, coupled with strength in Waukesha Cherry-Burrell and mixers more than offset the challenges in the former Industrial pumps segment. Given this performance and the backlog for Q4, we are confident SPX FLOW will achieve high single-digit growth in 2026. Also, orders momentum continues to be strong, resulting in a book-to-bill of 1.04x year-to-date, and the backlog growing 7% versus the prior year. As we look ahead, our focus is on unlocking SPX FLOW's growth potential by deploying the IT playbook of driving market share gains and relentless execution, both operationally and commercially. In Nutrition & Health, we're simplifying the organization to increase accountability, eliminate bureaucracy and accelerate decision-making was driving more innovation and leveraging an already strong customer intimacy. I was able to experience this intimacy firsthand when I met with Danone's leadership team in Paris. This partnership is exceptional. Our teams are working side-by-side to develop capital plans and design specialized equipment to improve productivity, increase throughput and reduce energy consumption to help the Danone win. This level of partnership is a powerful competitive advantage that helps us secure long-term growth opportunities. In mixers, we are utilizing our technical leadership to expand aftermarket penetration and we are driving productivity VA/VE initiatives to improve cost competitiveness. For the future, we're also now laying the groundwork to deliver on the revenue synergies through localization in Latin America and the Middle East, leveraging the Goulds footprint and network. At Waukesha Cherry-Burrell, we're expanding our TAM by growing our presence in China and India and by entering the attractive industrial process market. And we're already leveraging our installed base and customer relationships to drive share gains in North America for our Bornemann hygienic twin screw pump platform. In industrial pumps, the picture is mixed. Bran+Luebbe pumps on one hand, need to get closer to our customers in Asia and the Middle East by localizing assembly as well as engineering whilst resizing our European operations. On the other hand, our Johnson Pumps engineered and manufactured in India have successfully conquered the Indian market. We can leverage this competitive product to expand sales globally. I was fortunate to spend time with Sergit and his team in our plant in India. It's a great plant, a good team, and we will invest into this business. On cost synergies, we are ahead. The team has built a robust pipeline of synergies well surpassing our original $80 million target. For Q3 '26, we targeted $15 million of savings. And since closing in just 8 months, we are projecting savings of over $20 million by year-end. This translates to an annual run rate greater than $30 million. Corporate and business unit G&A synergies are executed, supply chain and procurement actions are well underway and will deliver savings in year 2. While it is still early innings, were performing well ahead of plan. Thank you, Lori, Bartek, the entire team and the EYP team for your hard work and for delivering these amazing results. With that, let me turn the call over to Mike to discuss Q3 results in more detail.